If you or someone around you experiences symptoms associated with Alzheimer's disease, between the ages of 65 and 90, and has a committed caregiver, you may be eligible to participate in a clinical research study evaluating the drug in the phase of development. research AXS-05. This study, conducted at specific centers in the US and Canada, offers the potential to contribute to the advancement of treatments for agitation linked to Alzheimer's disease.